NSE BSE
gkb ophthalmics ltd. stock

GKB OPHTHALMICS LTD. Share Price

- - (%)
- NSE: GKB

GKB OPHTHALMICS LTD. Share Price Update

As of the latest trading session, GKB OPHTHALMICS LTD. share price is currently at 103, which is down by -0.50 from its previous closing. Today, the stock has fluctuated between 100.05 and 103.50. Over the past year, GKB OPHTHALMICS LTD. has achieved a return of 17.53 %. In the last month alone, the return has been 6.57 %. Read More...

GKB OPHTHALMICS LTD. Performance

Day Range

Low100.05 High103.50
102.00

52 Week Range

Low 74.10 High 136.40
102.00

GKB OPHTHALMICS LTD. Share Price

533212

GKB

img img img img
No Data Available

Open Price

103.50

Prev. Close

103.50

Volume (Shares)

6409.00

Total traded value

6.50

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

GKB OPHTHALMICS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 51.91
PE Ratio (TTM) 0.00
Book Value / Share 47.59
Beta 0.77
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -1.37

GKB OPHTHALMICS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 7.36
Operating Expense 8.88
Net Profit -1.37
Net Profit Margin (%) -18.61
Earnings Per Share (EPS) -2.73
EBITDA -0.21
Effective Tax Rate (%) -3.00
Particulars DEC 2023 (Values in Cr)
Revenue 6.84
Operating Expense 8.87
Net Profit -0.31
Net Profit Margin (%) -4.53
Earnings Per Share (EPS) -0.61
EBITDA 0.71
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 7.27
Operating Expense 9.15
Net Profit -1.81
Net Profit Margin (%) -24.89
Earnings Per Share (EPS) -3.59
EBITDA -0.78
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 9.71
Operating Expense 9.71
Net Profit 0.08
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.15
EBITDA 1.09
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 6.47
Operating Expense 8.93
Net Profit -2.12
Net Profit Margin (%) -32.76
Earnings Per Share (EPS) -4.20
EBITDA -0.25
Effective Tax Rate (%) 4.09
Particulars MAR 2024 (Values in Cr)
Revenue 31.18
Operating Expense 36.63
Net Profit -3.42
Net Profit Margin (%) -10.96
Earnings Per Share (EPS) -6.78
EBITDA 0.80
Effective Tax Rate (%) -1.18
Particulars MAR 2023 (Values in Cr)
Revenue 27.73
Operating Expense 32.86
Net Profit -2.88
Net Profit Margin (%) -10.38
Earnings Per Share (EPS) -5.72
EBITDA 1.00
Effective Tax Rate (%) 5.26
Particulars MAR 2022 (Values in Cr)
Revenue 27.05
Operating Expense 31.32
Net Profit -2.31
Net Profit Margin (%) -8.53
Earnings Per Share (EPS) -4.58
EBITDA 1.52
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 21.34
Operating Expense 26.25
Net Profit -2.11
Net Profit Margin (%) -9.88
Earnings Per Share (EPS) -4.18
EBITDA 2.04
Effective Tax Rate (%) 7.86
Particulars MAR 2020 (Values in Cr)
Revenue 25.56
Operating Expense 31.12
Net Profit -4.17
Net Profit Margin (%) -16.31
Earnings Per Share (EPS) -8.28
EBITDA 0.65
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 124.38
ROE % 0.22
ROCE % 2.28
Total Debt to Total Equity 0.18
EBITDA Margin 6.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 125.17
ROE % 3.09
ROCE % 4.47
Total Debt to Total Equity 0.19
EBITDA Margin 8.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 124.30
ROE % 0.43
ROCE % 2.79
Total Debt to Total Equity 0.22
EBITDA Margin 9.24
Particulars MAR 2020 (Values in Cr)
Book Value / Share 117.55
ROE % -3.23
ROCE % -0.52
Total Debt to Total Equity 0.26
EBITDA Margin 5.54
Particulars MAR 2019 (Values in Cr)
Book Value / Share 111.84
ROE % -5.09
ROCE % -2.45
Total Debt to Total Equity 0.24
EBITDA Margin 3.50
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin 3.61
Particulars MAR 2022 (Values in Cr)
Book Value / Share 60.32
ROE % -7.31
ROCE % -2.12
Total Debt to Total Equity 0.38
EBITDA Margin 5.62
Particulars MAR 2021 (Values in Cr)
Book Value / Share 65.01
ROE % -3.23
ROCE % 0.13
Total Debt to Total Equity 0.32
EBITDA Margin 14.29
Particulars MAR 2020 (Values in Cr)
Book Value / Share 69.93
ROE % -11.93
ROCE % -6.16
Total Debt to Total Equity 0.29
EBITDA Margin 2.54
Particulars MAR 2019 (Values in Cr)
Book Value / Share 74.71
ROE % -13.70
ROCE % -7.97
Total Debt to Total Equity 0.32
EBITDA Margin 0.43
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.45
Total Assets 112.26
Total Liabilities 112.26
Total Equity 67.29
Share Outstanding 5040600
Price to Book Ratio 1.99
Return on Assets (%) -0.14
Return on Capital (%) -0.21
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 16.39
Total Assets 110.15
Total Liabilities 110.15
Total Equity 67.41
Share Outstanding 5040600
Price to Book Ratio 1.53
Return on Assets (%) 1.15
Return on Capital (%) 1.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 17.28
Total Assets 106.81
Total Liabilities 106.81
Total Equity 66.30
Share Outstanding 5040600
Price to Book Ratio 1.26
Return on Assets (%) -0.84
Return on Capital (%) -1.16
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 13.86
Total Assets 102.25
Total Liabilities 102.25
Total Equity 59.25
Share Outstanding 5040580
Price to Book Ratio 0.61
Return on Assets (%) -1.79
Return on Capital (%) -2.47
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 10.04
Total Assets 93.43
Total Liabilities 93.43
Total Equity 54.80
Share Outstanding 4640580
Price to Book Ratio 1.24
Return on Assets (%) -1.18
Return on Capital (%) -1.6
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 49.14
Total Liabilities 49.14
Total Equity 27.51
Share Outstanding 5040600
Price to Book Ratio 1.99
Return on Assets (%) -5.86
Return on Capital (%) -7.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.43
Total Assets 53.89
Total Liabilities 53.89
Total Equity 30.40
Share Outstanding 5040600
Price to Book Ratio 1.53
Return on Assets (%) -4.28
Return on Capital (%) -5.48
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.09
Total Assets 56.86
Total Liabilities 56.86
Total Equity 32.77
Share Outstanding 5040600
Price to Book Ratio 1.26
Return on Assets (%) -3.70
Return on Capital (%) -4.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.35
Total Assets 56.68
Total Liabilities 56.68
Total Equity 35.24
Share Outstanding 5040580
Price to Book Ratio 0.61
Return on Assets (%) -7.35
Return on Capital (%) -9.22
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 6.61
Total Assets 55.16
Total Liabilities 55.16
Total Equity 34.67
Share Outstanding 4640580
Price to Book Ratio 1.24
Return on Assets (%) -5.03
Return on Capital (%) -6.21
Particulars MAR 2023 (Values in Cr)
Net Income 0.13
Cash from Operations -2.60
Cash from Investing 1.42
Cash from Financing -2.18
Net change in Cash -3.52
Free Cash Flow -0.95
Particulars MAR 2022 (Values in Cr)
Net Income 1.94
Cash from Operations 5.14
Cash from Investing -3.52
Cash from Financing -1.66
Net change in Cash -0.12
Free Cash Flow 9.90
Particulars MAR 2021 (Values in Cr)
Net Income -0.92
Cash from Operations 6.89
Cash from Investing -16.77
Cash from Financing 2.76
Net change in Cash -7.15
Free Cash Flow 13.22
Particulars MAR 2020 (Values in Cr)
Net Income -1.83
Cash from Operations 3.27
Cash from Investing -3.72
Cash from Financing 4.29
Net change in Cash 3.83
Free Cash Flow 7.13
Particulars MAR 2019 (Values in Cr)
Net Income -1.57
Cash from Operations 3.94
Cash from Investing -9.89
Cash from Financing 13.13
Net change in Cash 7.15
Free Cash Flow 17.14
Particulars MAR 2023 (Values in Cr)
Net Income -3.03
Cash from Operations -1.10
Cash from Investing 2.39
Cash from Financing -2.02
Net change in Cash -0.77
Free Cash Flow -0.29
Particulars MAR 2022 (Values in Cr)
Net Income -2.30
Cash from Operations 2.33
Cash from Investing -0.83
Cash from Financing -1.49
Net change in Cash 0.00
Free Cash Flow 6.14
Particulars MAR 2021 (Values in Cr)
Net Income -2.28
Cash from Operations 2.11
Cash from Investing -11.52
Cash from Financing 0.61
Net change in Cash -8.80
Free Cash Flow 5.75
Particulars MAR 2020 (Values in Cr)
Net Income -4.17
Cash from Operations 6.14
Cash from Investing -5.68
Cash from Financing 3.30
Net change in Cash 3.75
Free Cash Flow 9.94
Particulars MAR 2019 (Values in Cr)
Net Income -3.25
Cash from Operations 5.34
Cash from Investing -8.63
Cash from Financing 9.20
Net change in Cash 5.88
Free Cash Flow 18.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
GKB OPHTHALMICS LTD. 102.00 0.00 0.86 51.41 74.10 / 136.40
BRITANNIA INDUSTRIES LTD 5880.95 66.13 35.93 141653.44 4349.95 / 5975.00
FOODS & INNS LIMITED 146.70 23.36 2.07 858.16 127.00 / 222.35
HINDUSTAN UNILEVER LTD. 2726.65 62.37 12.50 640651.30 2170.25 / 2750.00
MILKFOOD LTD. 676.15 67.48 2.35 412.08 490.00 / 824.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
GKB OPHTHALMICS LTD. 102.00 0.00 2.14 51.41 74.10 / 136.40
BRITANNIA INDUSTRIES LTD 5880.95 67.96 40.15 141653.44 4349.95 / 5975.00
COLGATE PALMOLIVE LTD. 3121.40 63.46 45.29 84897.60 1819.85 / 3154.00
NESTLE INDIA LIMITED 2598.90 78.59 75.00 250574.80 2145.28 / 2770.75
FOODS & INNS LIMITED 146.70 23.40 2.07 858.16 127.00 / 222.35

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 104.10
  • 26 Days 103.10
  • 10 Days 106.20
  • 50 Days 103.20
  • 12 Days 106.80
  • 100 Days 98.80
  • 20 Days 105.20
  • 200 Days 97.60
104.33
PIVOT
First Resistance 105.57
Second Resistance 107.63
Third Resistance 108.87
First Support 102.27
Second Support 101.03
Third Support 98.97
RSI 51.08
MACD 3.72
Commodity Channel Index (CCI) -63.68
ADX 36.20
Williams % R -80.40

Over 1 Month

down

6.57

Over 3 Months

down

10.73

Over 6 Months

down

5.20

Over 1 Year

down

17.53

Over 3 Years

down

3.49

Over 5 Years

down

10.90

GKB OPHTHALMICS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GKB OPHTHALMICS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
47.26
Promoter Holdings
50.94
FII
1.78
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Krishna Gopal Gupta Shareholding of Promoter and Promoter Group 902312.0 17.9
Vikram Gupta Shareholding of Promoter and Promoter Group 423105.0 8.39
Gaurav Gupta Shareholding of Promoter and Promoter Group 407966.0 8.09
Krishna Murari Gupta Public Shareholding 324207.0 6.43
Veena Gupta Shareholding of Promoter and Promoter Group 300753.0 5.97
Krishnagopal Gupta And Sons Shareholding of Promoter and Promoter Group 291351.0 5.78
Brijendra Kumar Gupta Public Shareholding 244950.0 4.86
Shefali Chawla Shareholding of Promoter and Promoter Group 242464.0 4.81
Somo Vision Co. Ltd. Public Shareholding 200000.0 3.97
Coeus Global Opportunities Fund Public Shareholding 90000.0 1.79
Usha Gupta Public Shareholding 76539.0 1.52
Dhwaja Commodity Services Private Limited Public Shareholding 72306.0 1.43
Lalit Kumar Gupta Public Shareholding 70500.0 1.4
Jyotivardhan Jaipuria Public Shareholding 66667.0 1.32
Tanvi Jignesh Mehta Public Shareholding 60691.0 1.2

GKB OPHTHALMICS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2010-09-21 1.2 Final 2010-09-23 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About GKB OPHTHALMICS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GKB OPHTHALMICS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of GKB Ophthalmics Ltd?

Answer Field

The share price of GKB Ophthalmics Ltd for NSE is ₹ 84.05 and for BSE is ₹ 102.00.

What is the Market Cap of GKB Ophthalmics Ltd?

Answer Field

The market cap of GKB Ophthalmics Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 51.40 Cr. as of now.

What is the 52 Week High and Low of GKB Ophthalmics Ltd?

Answer Field

The 52 Week High and Low of GKB Ophthalmics Ltd for NSE is ₹ 90.90 and ₹ 0.00 and for BSE is ₹ 136.40 and ₹ 74.10.

How to Buy GKB Ophthalmics Ltd share?

Answer Field

You can trade in GKB Ophthalmics Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for GKB Ophthalmics Ltd?

Answer Field

The 1 year returns on the stock has been 17.53%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader